Endo Tools Therapeutics secures €8 million ($9.5M) in Series D funding led by White Fund

January 19th 2021


Endo Tools Therapeutics (ETT), developers of advanced endoscopic medical devices for use by gastroenterologists, today announces the closing of a Series D funding round of €8 million ($9.5M), led by White Fund. The transaction is supported by new private investors and the existing investors (FPIM-SFPI, Epimède, Chagral Invest and private investors).  Please discover the press release here.